Profile
| Metric | Value |
|---|---|
| Full Name | Phibro Animal Health Corporation |
| Ticker | NASDAQ: PAHC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | pahc.com |
| Employees | 1,940 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $37.30 | |
| Price, 1D Change | -0.16% | |
| Market Cap | $2B | |
| TTM Dividend Yield | 1.29% | |
| PE Ratio | 22.43 | |
| Beta | 1.14 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +27.37% | |
| EPS | $1.19 | |
| EPS, 1Y Change | +1,890.77% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.12 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.19 | |
| EPS Estimate | N/A | $2.74 |
| EPS Est. Change | N/A | +130.88% |
| Revenue | $1.30B | |
| Revenue Estimate | N/A | $1.47B |
| Revenue Est. Change | N/A | +13.07% |
| Current Price | $37.30 | |
| Price Target | - | $45.00 |
| Price Tgt. Change | - | +20.64% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.12 | $0.06 | -94.68% | |
| $2.03 | $1.19 | -41.61% | |
| $2.74 | N/A | +130.88% | |
| $3.02 | N/A | +154.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.00B | $1.02B | +1.29% | |
| $1.28B | $1.30B | +1.40% | |
| $1.47B | N/A | +13.07% | |
| $1.51B | N/A | +16.78% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +79.93% | |
| Price, 3Y | +178.15% | |
| Market Cap, 1Y | +80.07% | |
| Market Cap, 3Y | +178.36% | |
| Revenue, 1Y | +27.37% | |
| Revenue, 3Y | +37.56% | |
| EPS, 1Y | +1,890.77% | |
| EPS, 3Y | -2.27% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $37.30 | |
| SMA 200 | $31.49 | |
| SMA 200 vs Price | -15.57% | |
| SMA 50 | $41.18 | |
| SMA 50 vs Price | +10.39% | |
| Beta | 1.14 | |
| ATR | $1.52 | |
| 14-Day RSI | 38.45 | |
| 10-Day Volatility | 41.87% | |
| 1-Year Volatility | 51.31% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.12 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.29% | |
| Total Dividend | $0.48 | |
| Dividends Paid | $19.45M | |
| Payout Ratio | 40.30% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.30B | |
| EPS | $1.19 | |
| Gross Profit | $390.97M | |
| Gross Margin | 30.16% | |
| Operating Profit | $121.29M | |
| Operating Margin | 9.36% | |
| Net Income | $48.26M | |
| Net Margin | 3.72% | |
| EBITDA | $166.89M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.67 | |
| Current Ratio | 2.76 | |
| Quick Ratio | 1.25 | |
| - | ||
| F-Score | 5 | |
| Altman Z-Score | 2.83 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 22.43 | |
| PS Ratio | 1.08 | |
| PB Ratio | 4.85 | |
| EV/EBITDA | 10.54 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $285.68M | |
| Cash & Equivalents | $77.04M | |
| Total Assets | $1.36B | |
| Current Assets | $810.61M | |
| Total Liabilities | $1.08B | |
| Current Liabilities | $293.47M | |
| Total Debt | $761.55M | |
| Short Term Debt | $25.38M | |
| Accounts Payable | $138.20M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.25B | |
| Operating Expenses | $269.68M | |
| Cost Of Goods Sold | $905.25M | |
| SG&A | $289.48M | |
| D&A | $45.61M | |
| Interest Expense | $0.00 | |
| Income Tax | $19.73M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $80.12M | |
| CFI | -$288.69M | |
| CFF | $207.13M | |
| Capex | $38.29M | |
| Free Cash Flow | $41.83M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| B of A Securities | → | |
| JP Morgan | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| Barclays | → | |
| JP Morgan | ||
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with PAHC
Data Sources & References
- PAHC Official Website www.pahc.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1069899/000110465925107001/0001104659-25-107001-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1069899/000155837025011776/0001558370-25-011776-index.htm
- PAHC Profile on Yahoo Finance finance.yahoo.com/quote/PAHC
- PAHC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pahc
FAQ
What is the ticker symbol for Phibro Animal Health Corporation?
The ticker symbol for Phibro Animal Health Corporation is NASDAQ:PAHC
Does Phibro Animal Health Corporation pay dividends?
Yes, Phibro Animal Health Corporation pays dividends. The last payment was $0.12, with an ex-dividend date on November 26, 2025
What sector is Phibro Animal Health Corporation in?
Phibro Animal Health Corporation is in the Healthcare sector
What industry is Phibro Animal Health Corporation in?
Phibro Animal Health Corporation is in the Specialty & Generic Drug Manufacturers industry
What country is Phibro Animal Health Corporation based in?
Phibro Animal Health Corporation is headquartered in United States
When did Phibro Animal Health Corporation go public?
Phibro Animal Health Corporation initial public offering (IPO) was on April 11, 2014
Is Phibro Animal Health Corporation in the S&P 500?
No, Phibro Animal Health Corporation is not included in the S&P 500 index
Is Phibro Animal Health Corporation in the NASDAQ 100?
No, Phibro Animal Health Corporation is not included in the NASDAQ 100 index
Is Phibro Animal Health Corporation in the Dow Jones?
No, Phibro Animal Health Corporation is not included in the Dow Jones index
When was Phibro Animal Health Corporation last earnings report?
Phibro Animal Health Corporation's most recent earnings report was on November 5, 2025
When does Phibro Animal Health Corporation report earnings?
The next expected earnings date for Phibro Animal Health Corporation is February 4, 2026
